Tang AY, Zhou M, Maillis AN, Lai KW, Lane PA, Snyder AB. Trends in
blood transfusion, hydroxyurea use, and iron overload among children
with sickle cell disease enrolled in Medicaid, 2004-2019. Pediatr Blood
Cancer. 2023;70(3):e30152. doi:10.1002/pbc.30152
2.
Ali MA, Ahmad A, Chaudry H, et al. Efficacy and safety of recently
approved drugs for sickle cell disease: a review of clinical trials. Exp
Hematol. 2020;92:11-18.e1.
doi:10.1016/j.exphem.2020.08.008
3.
Kanter J, Walters MC, Krishnamurti L, et al. Biologic and clinical
efficacy of LentiGlobin for sickle cell disease. N Engl J Med.
2022;386(7):617-628. doi:10.1056/NEJMoa2117175